Money Manager Provides Updates on Companies to Buy, Hold and Watch
Source: Adrian Day for Streetwise Reports  (4/30/21)
Money manager Adrian Day discusses developments at several companies, resource and otherwise. The selection includes some dividend-paying stocks, and includes several buys, including one strong buy. More >

Gold Discovery Firm's Final Metallurgical Drill Results 'Continue to Impress'
Source: Streetwise Reports  (4/29/21)
These final 2020 assays from Liberty Gold's Black Pine along with the company's 2021 exploration progress and upcoming catalysts are covered in a PI Financial report. More >

Sparing the Dime: The Dangers of Fudging Inflation Numbers
Source: Michael Ballanger for Streetwise Reports  (4/29/21)
Sector expert Michael Ballanger considers inflation and how market manipulations could have a detrimental affect on the gold bull, and describes how he's shifted his investing focus in response. More >

Galera Posts Positive Data from Phase 1/2 Pancreatic Cancer Trial
Source: Streetwise Reports  (4/29/21)
Galera Therapeutics shares traded 25% higher after the company reported new data from its Phase 1/2 pilot study of dismutase mimetic GC4419 that when used in combination with radiation therapy was shown to nearly double median overall survival time in patients with locally advanced pancreatic cancer. More >

Biopharma Study Shows Safety of Stem Cell Therapy in Severe COVID-19 Patients
Source: Streetwise Reports  (4/28/21)
The clinical trial, in which Sorrento Therapeutics established safety, and the company's next steps for this potential treatment are summarized in a Dawson James Securities report. More >

Company Receives Its Largest Order for Antibiotic-Free Animal Feed Product
Source: Streetwise Reports  (4/28/21)
Avivagen Inc. reported it received a 4.4 metric tonne purchase order for OxC-beta Livestock from UNAHCO representing its largest single order to date. More >

ADMA Biologics Granted FDA Approval to Boost IVIG Production by 50%
Source: Streetwise Reports  (4/28/21)
ADMA Biologics shares traded 9% higher after the company received FDA approval for increased intravenous immune globulin production scale, allowing the firm to increase manufacturing capacity from 400,000 to 600,000 liters and achieve peak revenues of greater than $300 million. More >

MMT: Medieval Monetary Theory
Source: Peter Krauth for Streetwise Reports  (4/28/21)
Peter Krauth of Gold Resource Investor provides his take on MMT and explains why he believes its effects will drive precious metals and commodities much higher. More >

As Copper Closes In on All-Time High, Meridian Mining Moving to Prove Up Historical Exploration
Source: The Critical Investor for Streetwise Reports  (4/28/21)
The Critical Investor delves into Meridian Mining's exploration at its 100% optioned Cabaçal VMS Copper-Gold Project in Brazil, and the first set of assays from a large drill program. More >

Looking Below the Surface for Nevada's Missing 200 Moz of Gold
Source: Streetwise Reports  (4/27/21)
Nevada Exploration is using new methods for finding prospective land in Nevada and should have an indication in six months if its concept bears out. More >

Explorer Expands Ontario Gold Project
Source: Streetwise Reports  (4/27/21)
The acquisition would increase Cross River Ventures' Manitou property land package to 6,570 hectares. More >

Gold Exploration Company Wraps Up Winter 2021 Diamond Drill Program, Releases First Assays
Source: Streetwise Reports  (4/27/21)
The first results of Black Tusk Resources' McKenzie East show gold mineralization is present in drill core veins and alterations. More >

Two Gold Discoveries Under the Radar
Source: Ron Struthers for Streetwise Reports  (4/27/21)
Ron Struthers of Struthers Resource Stock Report details the investment thesis for Galway Metals, which has two "advanced-stage" prospects in Canada. More >

Aldeyra's Drug Meets All Key Endpoints in Phase 3 Allergic Conjunctivitis Trial
Source: Streetwise Reports  (4/27/21)
Aldeyra Therapeutics shares traded 33% higher after the firm reported that reproxalap significantly met all primary and secondary endpoints in its Phase 3 allergic conjunctivitis study. More >

Low-Cost Uranium Project in Argentina to Meet Domestic Supply Demand
Source: Streetwise Reports  (4/26/21)
Blue Sky's Amarillo Grande Uranium-Vanadium Project in the Rio Negro province includes the flagship Ivana project, which boasts Argentina's largest NI 43-101 resource estimate for uranium, with a significant vanadium credit. More >

Miner Poised to Capitalize on Increasing Demand for Copper
Source: Peter Epstein for Streetwise Reports  (4/26/21)
Copper is gaining momentum, according to Peter Epstein of Epstein Research, and Pampa Metals is "cashed-up" and drilling for new discoveries "in the shadow of giants." More >

Nevada Explorer Enters JV with Hochschild
Source: Maurice Jackson for Streetwise Reports  (4/26/21)
Peter Ball, the CEO of NV Gold, updates Maurice Jackson of Proven and Probable on his company's recently announced partnership with Hochschild Mining on a project in the Cortez Gold Belt. More >

Roxgold Shares Trade Up 16% Following Fortuna Silver's CA$1.1 Billion Buyout Offer
Source: Streetwise Reports  (4/26/21)
Roxgold shares traded higher after the company reported it agreed to be acquired by Fortuna Silver Mines in a mostly stock and cash deal for CA$2.73 per share. More >

Royalty Firm's Gold Stream Highlighted as an Investment 'Success Story'
Source: Streetwise Reports  (4/23/21)
The highlights of Royal Gold's Investor Day are presented in a BMO Capital Markets report. More >

Canadian Company Acquires Stream on Near-Term Silver Production in Mexico
Source: Streetwise Reports  (4/23/21)
Why this royalty is an important stepping-stone for Empress Royalty is discussed in a Red Cloud Securities report. More >

Silver Enters Acceleration Phase
Source: Peter Krauth for Streetwise Reports  (4/23/21)
Peter Krauth of Silver Stock Investor discusses silver's rise and what may lie ahead. More >

WTI Crude Cracks $60 Again as OPEC Pumps Up Oil Demand Forecasts, US Shale Steadies Production
Source: McAlinden Research for Streetwise Reports  (4/23/21)
Energy demand continues to steadily rebound from the COVID crash, but several measures of supply show a continued downturn in oil inventories, reports McAlinden Research Partners. More >

Explorer's 3.7 Moz M&I Gold Resource Poised to Increase with Infill Drilling
Source: Streetwise Reports  (4/23/21)
BMO Capital Markets initiated coverage of Corvus Gold with an "Outperform (Speculative)" rating as it expects that additional exploration and infill drilling will expand Corvus' resource base, further driving a higher net asset value and share price multiple. More >

Will the Lithium Price Rebound Stick?
Source: Peter Epstein for Streetwise Reports  (4/23/21)
Peter Epstein of Epstein Research discusses whether the lithium price surge is a "flash in the battery metals pan" or whether the price will stay stronger for longer, and what this means for Cypress Development Corp. More >

Ocugen Reports $100 Million Direct Share Offering at Market Premium from Institutional Investors
Source: Streetwise Reports  (4/23/21)
Ocugen Inc. shares traded up as much as 47% before closing just 3.66% higher after the company announced a $100 million registered direct offering of common stock priced at a $10 per share, which represents a premium to the market price. More >